Aktie A1J5K5 TIANDA PHARMACEUTICALS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Tianda Pharmaceuticals Limited

Aktien

A1J5K5

KYG887471038

455

Markt geschlossen - Hong Kong S.E.
Andere Börsenplätze
 10:08:20 26.04.2024 		% 5 Tage % 1. Jan.
0,265 HKD +3,92 % Intraday Chart für Tianda Pharmaceuticals Limited +1,92 % +21,56 %
26.03. Tianda Pharmaceuticals Limited berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr CI
21.03. Tianda Pharmaceuticals Limited gibt konsolidierte Gewinnprognose für das laufende Jahr vom 1. Januar 2023 bis zum 31. Dezember 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Tianda Pharmaceuticals Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 28 June 2024
Tianda Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Tianda Pharmaceuticals Limited Provides Consolidated Earnings Guidance for the Current Year from 1 January 2023 to 31 December 2023
Tianda Pharmaceuticals Limited Announces Executive Changes, Effective 29 August 2023
Tianda Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended June 30, 2023
Tianda Pharmaceuticals to Shrink H1 Loss by Over 70%
Tianda Pharmaceuticals Limited Provides Consolidated Earnings Guidance for the Interim Period Ended June 30, 2023
Tianda Unit Buys Out 45% Stake in Meng Sheng Pharmaceutical
Tianda Pharmaceuticals Limited entered into an equity transfer agreement to acquire 45% stake in Yunnan Mengsheng Pharmaceutical Co., Ltd from Yunnan Linuo Biotechnology Co., Ltd. for HKD 23.5 million.
Tianda Pharmaceuticals Limited Announces Board Changes
Tianda Pharmaceuticals Limited Approves Final Dividend
Tianda Pharmaceuticals Limited Proposes Final Dividend for the Nine Months Ended 31 December 2022, Payable on or Before, 14 July 2023
Tianda Pharmaceuticals Unit to Invest HK$10 Million in Fund
Beijing Tong Ren Tang Chinese Medicine’s CEO Redesignated; New CEO Named
Tianda Pharmaceuticals Limited Announces Final Ordinary Dividend for the Nine Months Ended 31 December 2023
Tianda Pharmaceuticals Limited Reports Earnings Results for the Nine Months Ended December 31, 2022
Tianda Pharmaceuticals Limited Reports Earnings Results for the Nine Months Ended December 31, 2022
Tianda Pharmaceuticals Warns of Higher Loss in Fiscal Nine-Month Period; Shares Tumble 9%
Tianda Pharmaceuticals Limited Provides Group Earnings Guidance for the Nine Months Period from April 1, 2022 to December 31, 2022
Tianda Pharmaceuticals to Set Up Additional Production Line to Meet Rising Medicine Demand
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A1J5K5 Aktie
  4. Nachrichten Tianda Pharmaceuticals Limited
  5. Andere Sprachen